Predictive and prognostic value of microtubule-associated protein-tau and classes I to IV β-tubulin isotypes in locally advanced breast cancer

被引：0
|
作者：
Tibau, A. [1 ]
Lopez Vilaro, L. [2 ]
Anguera, G. [1 ]
Virgili, A. [1 ]
Perez-Olabarria, M. [2 ]
Vazquez, T. [2 ]
Gich, I. [3 ]
Alonso, C. [1 ]
Ojeda, B. [1 ]
Ramon y Cajal, T. [1 ]
Murata, P. [1 ]
Enrique, L. [2 ]
Escuin, D. [4 ]
Barnadas, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Pathol, Barcelona, Spain
[3] Hosp Santa Creu & Sant Pau, Dept Epidemiol, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Inst Invest Biomed, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30151-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
266
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 46 条
  • [31] Microtubule-associated protein tau is a marker of pathological complete response in Her-2/neu positive neoadjuvant treated breast cancer patients
    Rueckert, S.
    Wirtz, R.
    Lenhard, M.
    Hasmueller, S.
    Ditsch, N.
    Ruehl, I
    Kahlert, S.
    Bauerfeind, I
    Untch, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S89 - S90
  • [32] Microtubule-associated protein tau is a marker of pathological complete response in Her-2/neu positive neoadjuvant treated breast cancer patients
    Rueckert, S.
    Wirtz, R. M.
    Lenhard, M. S.
    Hasmueller, S.
    Ditsch, N.
    Ruehl, I.
    Kahlert, S.
    Bauerfeind, I.
    Fasching, P. A.
    Untch, M.
    EJC SUPPLEMENTS, 2008, 6 (07): : 191 - 192
  • [33] The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer
    Woolston, Caroline M.
    Zhang, Lei
    Storr, Sarah J.
    Al-Attar, Ahmad
    Shehata, Mohamed
    Ellis, Ian O.
    Chan, Stephen Y.
    Martin, Stewart G.
    MODERN PATHOLOGY, 2012, 25 (08) : 1106 - 1116
  • [34] Expression of the microtubule-associated protein, tau, predicts improved survival, but not response, to a combination of docetaxel and vinorelbine in HER-2 negative metastatic breast cancer
    Gralow, J. R.
    Barlow, W. E.
    Gown, A. M.
    Goldstein, L. C.
    Porter, P. L.
    Yeh, I. T.
    Livingston, R. B.
    Hayes, D. F.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S89 - S89
  • [35] Synergy between ixabepilone (Ixa) and trastuzumab (TZ): Investigation of the role of microtubule-associated protein (MAP-tau) and III tubulin (13111) in HER2-positive (HER2+) breast cancer (BC)
    Lee, Francis Y.
    Wen, Mei-Li
    Khambata-Ford, Shirin
    Fairchild, Craig
    Galbraith, Susan
    Horak, Christine E.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [36] GENE EXPRESSION OF ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND MICROTUBULE-ASSOCIATED PROTEIN TAU IN HIGH-RISK EARLY BREAST CANCER: A QUEST FOR MOLECULAR PREDICTORS OF TREATMENT BENEFIT
    Pentheroudakis, G.
    Kalogeras, K.
    Wirtz, R.
    Gogas, H.
    Pectasides, D.
    Samantas, E.
    Bafaloukos, D.
    Papakostas, P.
    Kalofonos, C.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 79 - 79
  • [37] Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial:: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response
    Rody, A.
    Karn, T.
    Gaetje, R.
    Ahr, A.
    Solbach, C.
    Kourtis, K.
    Munnes, M.
    Loibl, S.
    Kissler, S.
    Ruckhaeberle, E.
    Holtrich, U.
    von Minckwitz, G.
    Kaufmann, M.
    BREAST, 2007, 16 (01): : 86 - 93
  • [38] The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
    Hirokuni Ikeda
    Naruto Taira
    Fumikata Hara
    Takeo Fujita
    Hiromasa Yamamoto
    Junichi Soh
    Shinichi Toyooka
    Tomohiro Nogami
    Tadahiko Shien
    Hiroyoshi Doihara
    Shinichiro Miyoshi
    Breast Cancer Research, 12
  • [39] The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
    Ikeda, Hirokuni
    Taira, Naruto
    Hara, Fumikata
    Fujita, Takeo
    Yamamoto, Hiromasa
    Soh, Junichi
    Toyooka, Shinichi
    Nogami, Tomohiro
    Shien, Tadahiko
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    BREAST CANCER RESEARCH, 2010, 12 (03)
  • [40] Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial
    George Pentheroudakis
    Konstantine T. Kalogeras
    Ralph M. Wirtz
    Irene Grimani
    George Zografos
    Helen Gogas
    Udo Stropp
    Dimitrios Pectasides
    Dimosthenis Skarlos
    Guido Hennig
    Epaminondas Samantas
    Dimitrios Bafaloukos
    Pavlos Papakostas
    Haralabos P. Kalofonos
    Nicholas Pavlidis
    George Fountzilas
    Breast Cancer Research and Treatment, 2009, 116 : 131 - 143
12345